| Pembrolizumab investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 525show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 395 trials (181 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 395 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melanomacancer_family 229 trials (83 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Melanoma | 229 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasmcancer_family 179 trials (88 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 179 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Head and Neck Squamous Cell Carcinomasubtype 171 trials (81 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Head and Neck Squamous Cell Carcinoma | 171 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 137 trials (73 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 137 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 102 trials (46 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Renal Cell Carcinomasubtype 94 trials (37 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Renal Cell Carcinoma | 94 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasmcancer_family 89 trials (41 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 85 trials (45 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasmsubtype 82 trials (39 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 82 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Urothelial Carcinomasubtype 72 trials (38 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Urothelial Carcinoma | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hepatocellular Carcinomasubtype 61 trials (17 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hepatocellular Carcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasmcancer 59 trials (23 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Head and Neck Neoplasm 56 trials (25 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Head and Neck Neoplasm | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 52 trials (22 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 52 | Observed | clinicaltrials | graph → |